Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ILOTYCIN GLUCEPTATE

ERYTHROMYCIN GLUCEPTATE

Standard Dose
EQ 500MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ILOTYCIN GLUCEPTATE is listed in Drugs@FDA under application 050370 (NDA).

Marketing status: Discontinued Active ingredient ERYTHROMYCIN GLUCEPTATE Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor DISTA Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview ILOTYCIN GLUCEPTATE is listed in Drugs@FDA under application 050370 (NDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN GLUCEPTATE Form and strength INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Sponsor DISTA Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.